Justine Anastasia Barletta, M.D.
This page shows the publications co-authored by Justine Barletta and Michelle Hirsch.
p-120 Catenin is a Useful Diagnostic Biomarker for Distinguishing Plasmacytoid and Sarcomatoid Variants From Conventional Urothelial Carcinoma. Arch Pathol Lab Med. 2021 08 01; 145(8):1000-1008.
Key Renal Neoplasms With a Female Predominance. Adv Anat Pathol. 2021 Jul 01; 28(4):228-250.
Intestinal metaplasia of the urinary tract harbors potentially oncogenic genetic variants. Mod Pathol. 2021 02; 34(2):457-468.
GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract. Am J Surg Pathol. 2015 Oct; 39(10):1411-9.
GATA3 expression in gestational trophoblastic tissues and tumours. Histopathology. 2015 Nov; 67(5):636-44.
Immunohistochemical staining for BRAF V600E supports the diagnosis of metanephric adenoma. Histopathology. 2015 May; 66(6):901-4.
A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol. 2011 Jun; 35(6):816-26.
Histopathological and genetic features of mismatch repair-deficient high-grade prostate cancer. Histopathology. 2022 Jun; 80(7):1050-1060.
Grading Intraductal Carcinoma in Prostate Biopsies Changes Risk Categorization in a Small Subset of Cases. Arch Pathol Lab Med. 2021 07 01; 145(7):782-784.
Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract. Mod Pathol. 2015 Nov; 28(11):1504-14.
FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder. Cancer Med. 2014 Aug; 3(4):835-44.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.